Cinclus Pharma Holding AB (publ) (STO:CINPHA)

Sweden · Delayed Price · Currency is SEK

12.22

+0.06 (0.49%)

At close: Jun 15, 2026

Revenue by Segment

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Biotechnology (Startups)	57.47M	4.58M	5.96M	10.57M	-
Biotechnology (Startups) Growth	1154.80%	-23.14%	-43.63%	-	-
Total	57.47M	4.58M	5.96M	10.57M	-
Total Growth	1154.80%	-23.14%	-43.63%	-	-

Revenue by Geography

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
China	4.61M	4.58M	5.96M	10.57M	-
China Growth	0.72%	-23.14%	-43.63%	-	-
Czech Republic	52.86M	-	-	-	-
Total	57.47M	4.58M	5.96M	10.57M	-
Total Growth	1154.83%	-23.14%	-43.63%	-	-